Renalytix plc$RENX
GB00BYWL4Y04 · LSE
1 director and manager of Renalytix plc have disclosed 2 transactions under MAR Article 19: 1 buy worth €82k and 1 sell worth €82k, which reads as net buying. The most recent disclosed transaction was on 2026-09-29. The largest buy was Harwood Capital LLP* (Christopher Mills, Non-Executive Chairman, Chief Investment Officer of Harwood) for €82k. See live cluster buys or start a free 14-day trial to get alerts when Renalytix plc insiders trade.
Insiders
1
Net flow
€0
Bought
€82k
Sold
€82k
Buy Renalytix plc
Pick a broker. We handle the signal, they handle execution.
Affiliate links — we may earn a referral fee if you sign up.
All disclosed transactions
| Date | Type | Insider | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-09-29 2w ago | BUY | Harwood Capital LLP* Christopher Mills, Non-Executive Chairman, Chief Investment Officer of Harwood | 1,166,667 | €0.06 | €82k |
| 2026-09-29 2w ago | SELL | Harwood Capital LLP* Christopher Mills, Non-Executive Chairman, Chief Investment Officer of Harwood | 1,166,667 | €0.06 | €82k |